Harold Jacob's most recent trade in NanoVibronix Inc was a trade of 10,000 Option to Purchase Common Stock done . Disclosure was reported to the exchange on Dec. 30, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NanoVibronix Inc | Harold Jacob | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | |
NanoVibronix Inc | Harold Jacob | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 6,667 | 6,667 | - | - | Option to Purchase Common Stock | |
NanoVibronix Inc | Harold Jacob | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 3,333 | 3,333 | - | - | Option to Purchase Common Stock | |
NanoVibronix Inc | Jacob Harold | Director, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | |
NanoVibronix Inc | Jacob Harold | Director, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock |